Share on Pinterest Getty Images/Dragoljub Bankovic The FreeStyle Libre is a continuous glucose monitoring (CGM) system that doesn’t require a blood sample from a finger stick. It’s ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025. Foreign exchange remains ...

Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) technology use is linked to a significant decrease in hospitalisation risk for ...

Abbott announced results from its REFLECT real-world studies that show the use of FreeStyle Libre continuous glucose monitoring (CGM) technology is associated with a significant reduction in the risk ...

The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...

Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose monitoring (CGM) technology with the Medtronic automated insulin delivery ...

FreeStyle Libre is a continuous glucose monitoring (CGM) system that allows a person to check their blood sugar in real time without having to prick their finger. The system has two components ...

The company’s second-quarter report follows FDA green lights earlier this year for its first over-the-counter continuous glucose monitoring systems, the Lingo and Libre Rio, as well as an ...

Medtronic's 780g insulin pump automates much of the insulin delivery and can be integrated its own CGM or Libre. Though these competitive features could have peeled some Dexcom users away on the ...

May 15, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced results from its REFLECT real-world studies that show the use of FreeStyle Libre® continuous glucose monitoring (CGM) technology ...